COMMUNIQUÉS West-GlobeNewswire

Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
07/01/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Décembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/01/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition
07/01/2026
Regeneron Science Talent Search Marks Milestone 85th Year with $1.2 Million Awarded to Nation’s Most Promising Young Scientists and Their Schools WASHINGTON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Society for Science (the [...]
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
07/01/2026
PRESS RELEASE AB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA The combination [...]
AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1
07/01/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE UN QUATRIÈME CAS CONSÉCUTIF DE RÉPONSE AVEC LA COMBINAISON D’AB8939 ET DU VENETOCLAX DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË RÉFRACTAIRE OU EN RECHUTE, SUR LA BASE DES [...]
Comprehensive Healthcare Welcomes Community Behavioral Health Veteran as Chief Medical Officer
07/01/2026
YAKIMA, Wash., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare, the leading community behavioral health provider in Central and Southwest Washington, is proud to welcome Mark Bradshaw, M.D., as its new chief [...]
GENFIT Announces 2026 Financial Calendar
07/01/2026
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare [...]
GENFIT annonce son calendrier financier pour 2026
07/01/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 7 janvier 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des [...]
National Institutes of Health Awards $1.54M Grant To Scottish Rite for Children for Rare Diseases Research
07/01/2026
Promising Hydrogel Could Help Kids Walk Again and Adults Avoid Invasive Surgery Dallas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Every year, thousands of children and adults face the crippling effects of osteonecrosis. Now, [...]
Neocis Surpasses 100,000 Robotic Osteotomies with the Yomi Platform
07/01/2026
Landmark milestone demonstrates proven robotic adoption as the next generation Yomi S completes the first real world cases MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Neocis, the market leader behind the Yomi® robotic [...]
Cullgen Announces Conference Participation During J.P. Morgan Healthcare Conference Week
07/01/2026
- Updated corporate presentation posted to website - SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and [...]
Scottish Rite for Children Receives $2.3M NIH Grant to Advance Bone Regeneration Research in Children With Perthes Disease
07/01/2026
Findings may help develop faster-healing treatments for Perthes and similar bone conditions Dallas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Researchers at Scottish Rite for Children received a $2.3 million, five-year grant [...]
USOSM Continues Growth Momentum
07/01/2026
Announces New Partner Practice in Union City, California IRVING, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
07/01/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 7 JANUARY 2026 at 16:30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
New Study Reveals Lack of Certainty Around Processed Fats and Heart Health
07/01/2026
Research Has Shown Some Processed Fats Don’t Influence Heart Health as Expected. Anathapindika’s Detoxing Supplements Offer Additional, Natural Heart Health Support. Fort Lauderdale, FL, Jan. 07, 2026 (GLOBE NEWSWIRE [...]
Anathapindika Health Enters New Partnership With Green’s Nutrition
07/01/2026
The Detoxification Supplement Brand Adds Another California Store to Its West Coast Takeover Fort Lauderdale, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Anathapindika Health is a nutraceutical brand focused on supplements [...]
Weight Watchers to Participate in Upcoming Investor Conferences
07/01/2026
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that the Company will be [...]
VIVUS Introduces Lower Pricing on QSYMIA® at Costco Locations Across Hawaii
07/01/2026
— Through this program, QSYMIA will be available for less than $2.33 a day/$69 a month at participating Costco Pharmacies in Hawaii CAMPBELL, Calif. and HONOLULU, Jan. 07, 2026 (GLOBE NEWSWIRE) -- VIVUS LLC, a [...]
Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference
07/01/2026
LEXINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to [...]

Pages